Los Altos, CA, United States of America

George Andrew Watson

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Mind: The Contributions of George Andrew Watson**

Introduction

George Andrew Watson, an innovative inventor based in Los Altos, California, has made significant contributions to the field of molecular diagnostics, particularly in relation to kidney cancer. With a total of two patents to her name, Watson has utilized her expertise to develop algorithms that enhance the accuracy of cancer recurrence assessments.

Latest Patents

Watson's latest innovations include a gene expression profile algorithm designed for calculating a recurrence score for patients diagnosed with kidney cancer. This groundbreaking invention involves the measurement of expression levels of specific genes from biological samples collected from kidney cancer patients. By grouping these genes into functional subsets, the algorithm calculates a quantitative score that reflects the risk of cancer recurrence. Furthermore, the subsets of genes can be weighted based on their respective contributions to cancer recurrence, thereby offering a more precise and individualized assessment for patients.

Career Highlights

Currently, Watson is employed at Genomic Health, Inc., where she continues to push the boundaries of cancer diagnostics. Her role at the company has allowed her to focus on the intersection of genomics and patient outcomes, fostering advancements in personalized medicine.

Collaborations

Throughout her career, Watson has collaborated with esteemed colleagues such as Steven Shak and Michael R. Crager, both of whom share her commitment to innovation in the healthcare sector. Together, they have worked on projects that aim to improve the predictive capabilities of molecular assays, benefiting patients with various forms of cancer.

Conclusion

George Andrew Watson stands out as a prominent figure in the world of medical innovation, specifically in the realm of cancer diagnostics. Her patents and collaborative efforts not only showcase her dedication to improving patient care but also highlight the importance of advancements in genomic research. As she continues her work at Genomic Health, Inc., the impact of her contributions is poised to resonate within the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…